Between 27-29 October 2021, HUMVO (The Hungarian Medicines Verification Organisation) hosted the meeting of Quality Assurance representatives of National Medicines Verification Organisations (NMVO) – Arvato Customer Group, coordinated by the QA Council, where OSMR was represented by #Elena Georgescu – Quality Assurance Director. The meeting involved the participation of Arvato’s representatives and had EMVO, SolidSoft […]
As a continuation of the communication related to the planned deployment dates for EU Hub Release 1.10, EMVO announced the confirmation of deployment to the Integrated Test Environment (ITE). EMVO LoA
Please click on the link below for more details on the planned deployment dates for ITE, IQE & PRD in the latest EMVO Letter of Announcement. EMVO LoA
Below you can find new information related to the Pilot phase of the Alert Management System (AMS) project, which started on October 4th, as scheduled. EMVO LoA
The series of short summaries related to the activity carried out by our team: Spotlight on the OSMR Team, continues with our colleague: Alexandru Neagu, IT Manager and Alert Flow Architect. Alex has been involved in the serialisation project since the beginning of 2018, providing IT logistical support and assistance on technical issues. Gradually, Alex […]
Please find bellow the Letter of Announcement from EMVO stating that verifications can only be carried out for packs under physical possession of an OBP. EMVO LoA
In the latest EMVO Letter of Announcement you can find more details about irreversible transactions. EMVO LoA
Patient safety has proven to be a priority at the European level by the passing of the Falsified Medicines Directive in June 2011. Thus, according to Directive 2011/62/EU of the European Parliament and of the Council, amending Directive 2001/83/EC on the Community code relating to medicinal products for human use, as regards the prevention of […]
New information about the Alert Management System is available in the latest EMVO Letter of Announcement. EMVO LoA







